Workflow
MEDIROM Healthcare Technologies(MRM)
icon
Search documents
MEDIROM Healthcare Technologies(MRM) - 2022 Q4 - Annual Report
2022-12-27 11:01
Exhibit 99.1 December 27, 2022 MEDIROM Healthcare Technologies Inc. Reports Financial Results for the Six Months Ending June 30, 2022 and Provides Corporate Update New York – December 27, 2022 – MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM, "MEDIROM" or the "Company"), a leading holistic health services provider in Japan, today announced its interim financial results for the six months ended June 30, 2022. Provided below is a discussion and analysis of the Company's financial condition and results of ...
MEDIROM Healthcare Technologies(MRM) - 2021 Q4 - Annual Report
2022-11-14 20:47
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 Table of Contents OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE AC ...
MEDIROM Healthcare Technologies(MRM) - 2020 Q4 - Annual Report
2021-05-17 20:29
Exhibit 99.1 May 17, 2021 MEDIROM Healthcare Technologies Inc. Reports Financial Results for the Year Ending 2020 and Provides Corporate Update Conference Call to be held Monday May 17, 2021 at 4:30 p.m. ET New York — May 17, 2021 — MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM, "MEDIROM"), a leading holistic health services provider in Japan, today announced MEDIROM's financial results for the year ended December 31, 2020. FY 2020 Financial Highlights Corporate Highlights FY 2020 · Total revenue decr ...
MEDIROM Healthcare Technologies(MRM) - 2020 Q4 - Annual Report
2021-05-17 10:15
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ◻ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ⌧ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ◻ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE AC ...